CDKN1A and cancer: The NIK-NF-κB2 pathway is recognized for driving cell proliferation in cancer by suppressing the expression of the cell cycle inhibitor p21.44 We investigated whether this pathway is conserved in EC and demonstrated that c-REL-NFKB2 signalling represses p21 under low shear stress conditions.